THE GLUTAMATE UPTAKE INHIBITOR L-TRANS-2,4-PYRROLIDINE DICARBOXYLATE IS NEUROTOXIC IN NEONATAL RAT-BRAIN

被引:7
作者
BARKS, JDE [1 ]
SILVERSTEIN, FS [1 ]
机构
[1] UNIV MICHIGAN,DEPT NEUROL,ANN ARBOR,MI 48109
关键词
EXCITOTOXICITY; EXCITATORY AMINO ACIDS; L-TRANS-2,4-PYRROLIDINE DICARBOXYLATE; DL-THREO-BETA-HYDROXYASPARTATE; GLUTAMATE UPTAKE; HIPPOCAMPUS; PERINATAL; NEONATAL; HYPOXIA; HYPOXIA-ISCHEMIA;
D O I
10.1007/BF02815412
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
High-affinity glutamate uptake (HAGU) transporters rapidly remove released glutamate from the synaptic cleft. If HAGU is suppressed, neurotoxic concentrations of excitatory amino acids may accumulate. To seek further evidence in support of the neurotoxicity of endogenous glutamate in the developing brain, we assessed the neurotoxicity of the selective HAGU inhibitor L-trans-2,4-pyrrolidine dicarboxylate (L-PDC) in postnatal day 7 (PND 7) rats. The hippocampus of PND 7 rats is susceptible to EAA agonist-mediated injury; features of injury include atrophy and neuronal loss. Since HAGU is energy-dependent, we hypothesized that moderate hypoxia would increase L-PDC-mediated injury by further suppressing HAGU. L-PDC was stereotaxically injected into dorsolateral hippocampus of PND 7 rats (568 nmol, n = 20). Prior to return to the dam, rats were divided into two groups, one of which was subjected to moderate hypoxia (3 h, FiO2 = 0.08) (n = 11; 2 died acutely). On PND 12, hippocampal neuropathology was assessed by a blinded observer using a five-point scale and also by measuring hippocampal cross-sectional areas with computerized image analysis. Three brains were excluded from analysis, since markedly asymmetric tissue sectioning precluded valid side-to-side comparison of hippocampal areas. Injection of L-PDC alone elicited focal pyramidal cell loss (6/7); in the (L-PDC + hypoxia) group, injury was significantly increased (median scores: L-PDC = 2; L-PDC + hypoxia] = 3.5; p < 0.005). Hippocampal atrophy was noted only after L-PDC + hypoxia (4/8) (percent right-left difference in mean hippocampal area [+/-SE]: L-PDC = 2.5% [+/-2.6]; [L-PDC + hypoxia] = 8.9% [+/-3.2]; p < 0.02). In tissue from PND 7 rats, L-PDC (10 mu M) inhibited hippocampal synaptosomal HAGU by > 85%; at the same concentration, L-PDC did not displace [H-3]glutamate from NMDA- or AMPA-sensitive hippocampal binding sites. These results support the hypothesis that increased synaptic accumulation of endogenous excitatory amino acid neurotransmitters may produce hippocampal injury in perinatal rodents.
引用
收藏
页码:201 / 215
页数:15
相关论文
共 30 条
[1]   INTRACELLULAR AND EXTRACELLULAR CHANGES OF AMINO-ACIDS IN THE CEREBRAL-CORTEX OF THE NEONATAL RAT DURING HYPOXIC-ISCHEMIA [J].
ANDINE, P ;
SANDBERG, M ;
BAGENHOLM, R ;
LEHMANN, A ;
HAGBERG, H .
DEVELOPMENTAL BRAIN RESEARCH, 1991, 64 (1-2) :115-120
[2]  
Barks John D. E., 1992, Society for Neuroscience Abstracts, V18, P1148
[3]   CONFORMATIONALLY DEFINED NEUROTRANSMITTER ANALOGS - SELECTIVE-INHIBITION OF GLUTAMATE UPTAKE BY ONE PYRROLIDINE-2,4-DICARBOXYLATE DIASTEREOMER [J].
BRIDGES, RJ ;
STANLEY, MS ;
ANDERSON, MW ;
COTMAN, CW ;
CHAMBERLIN, AR .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) :717-725
[4]  
Butler A. K., 1993, Society for Neuroscience Abstracts, V19, P1777
[5]   PROPERTIES OF QUISQUALATE-SENSITIVE L-[H-3]GLUTAMATE BINDING-SITES IN RAT-BRAIN AS DETERMINED BY QUANTITATIVE AUTORADIOGRAPHY [J].
CHA, JHJ ;
GREENAMYRE, JT ;
NIELSEN, EO ;
PENNEY, JB ;
YOUNG, AB .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (02) :469-478
[6]  
Conover WJ, 1980, PRACTICAL NONPARAMET, P229
[7]   MK-801 PREVENTS HIPPOCAMPAL NEURODEGENERATION IN NEONATAL HYPOXIC-ISCHEMIC RATS [J].
FORD, LM ;
SANBERG, PR ;
NORMAN, AB ;
FOGELSON, MH .
ARCHIVES OF NEUROLOGY, 1989, 46 (10) :1090-1096
[8]   GLUTAMATE TOXICITY - AN EXPERIMENTAL AND THEORETICAL-ANALYSIS [J].
GARTHWAITE, G ;
WILLIAMS, GD ;
GARTHWAITE, J .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1992, 4 (04) :353-360
[9]   EFFECTS OF PERINATAL STROKE ON STRIATAL AMINO-ACID EFFLUX IN RATS STUDIED WITH INVIVO MICRODIALYSIS [J].
GORDON, KE ;
SIMPSON, J ;
STATMAN, D ;
SILVERSTEIN, FS .
STROKE, 1991, 22 (07) :928-932
[10]   L-TRANS-PYRROLIDINE-2,4-DICARBOXYLATE AND CIS-1-AMINOCYCLOBUTANE-1,3-DICARBOXYLATE BEHAVE AS TRANSPORTABLE, COMPETITIVE INHIBITORS OF THE HIGH-AFFINITY GLUTAMATE TRANSPORTERS [J].
GRIFFITHS, R ;
DUNLOP, J ;
GORMAN, A ;
SENIOR, J ;
GRIEVE, A .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (02) :267-274